No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.
Also called NCT02128191
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 142 participants
- Sponsor
- Registry
-
NCT02128191
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02128191. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2019-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants
- Condition
- Bronchopulmonary Dysplasia (BPD)
- Intervention (Drug)
- Oral ibuprofen
- Intervention (Drug)
- Normal saline
- Lead sponsor
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct02128191- Content hash
1326bfb7f5c88dee4c2167cbecb2d8b984cb5b5e8814d929089d0ea5e7d767cc